These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21333079)

  • 1. Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis.
    O'Connell OJ; O'Farrell C; Harrison MJ; Eustace JA; Henry MT; Plant BJ
    Respir Care; 2011 Jun; 56(6):771-5. PubMed ID: 21333079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertonic saline and PEP: is it worth a try?
    O'Malley CA
    Respir Care; 2011 Jun; 56(6):886-7. PubMed ID: 21679498
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.
    Gupta S; Ahmed F; Lodha R; Gupta YK; Kabra SK
    J Trop Pediatr; 2012 Oct; 58(5):375-81. PubMed ID: 22374985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, randomized, double-blind, controlled study.
    Furnari ML; Termini L; Traverso G; Barrale S; Bonaccorso MR; Damiani G; Piparo CL; Collura M
    Ther Adv Respir Dis; 2012 Dec; 6(6):315-22. PubMed ID: 22968159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhaled therapies for cystic fibrosis].
    Lahzami S; Nicod LP
    Rev Med Suisse; 2011 Nov; 7(318):2285-8. PubMed ID: 22400363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled hypertonic saline as a therapy for cystic fibrosis.
    Elkins MR; Bye PT
    Curr Opin Pulm Med; 2006 Nov; 12(6):445-52. PubMed ID: 17053496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing.
    Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R
    Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of bronchodilator responses to albuterol delivered by ultrasonic versus jet nebulization in moderate to severe asthma.
    Pallares DE; Pilarski BR; Rodriguez JL; Leickly FE
    Ann Allergy Asthma Immunol; 1996 Oct; 77(4):292-7. PubMed ID: 8885806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
    Reeves EP; Williamson M; O'Neill SJ; Greally P; McElvaney NG
    Am J Respir Crit Care Med; 2011 Jun; 183(11):1517-23. PubMed ID: 21330456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of positive expiratory pressure devices attached to nebulizers.
    Berlinski A
    Respir Care; 2014 Feb; 59(2):216-22. PubMed ID: 23920213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
    Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD;
    JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonic saline for cystic fibrosis: worth its salt?
    Goralski JL; Donaldson SH
    Expert Rev Respir Med; 2014 Jun; 8(3):267-9. PubMed ID: 24666113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
    Amin R; Subbarao P; Jabar A; Balkovec S; Jensen R; Kerrigan S; Gustafsson P; Ratjen F
    Thorax; 2010 May; 65(5):379-83. PubMed ID: 20435858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulized 5% or 3% hypertonic or 0.9% saline for treating acute bronchiolitis in infants.
    Al-Ansari K; Sakran M; Davidson BL; El Sayyed R; Mahjoub H; Ibrahim K
    J Pediatr; 2010 Oct; 157(4):630-4, 634.e1. PubMed ID: 20646715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
    Elkins MR; Robinson M; Rose BR; Harbour C; Moriarty CP; Marks GB; Belousova EG; Xuan W; Bye PT;
    N Engl J Med; 2006 Jan; 354(3):229-40. PubMed ID: 16421364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring airway surface liquid in cystic fibrosis.
    Ratjen F
    N Engl J Med; 2006 Jan; 354(3):291-3. PubMed ID: 16421371
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal airway antimicrobial therapy for cystic fibrosis: the role of inhaled aztreonam lysine.
    Elborn JS; Henig NR
    Expert Opin Pharmacother; 2010 Jun; 11(8):1373-85. PubMed ID: 20426707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
    Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
    J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.